Neuropathic Pain Market Size, Share, Global Insights and Analysis

Neuropathic Pain pipeline therapeutics constitutes close to 236 molecules. Out of which approximately 202 molecules are developed by Companies and remaining by the Universities/Institutes. Global Markets Direct's latest report Neuropathic Pain – Pipeline Review, H1 2016, outlays comprehensive information on the therapeutics under development for Neuropathic Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

Neuropathic Pain Neuropathic pain, or neuralgia, is a condition in which the sensory system is affected. It is commonly accompanied by tissue injury. The nerve fibres could be damaged resulting in the generation of abnormal signals. Neuropathic pain is also exhibited along with many other diseases. The symptoms might include shooting pain and numbness. Several factors are involved in causing neuropathic pain however there seems to be no specific reason. Trauma, kidney disease, alcoholism, infections, stress etc may lead to painful symptoms. The condition may be controlled by the use of medications and psychological therapies. The molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 7, 28, 28, 1, 1, 114, 20 and 2 respectively. Similarly, the Universities portfolio in Phase I, Preclinical and Discovery stages comprises 1, 32 and 1 molecules, respectively.

Browse full report with TOC@ https://marketreportscenter.com/reports/338306/neuropathic-pain-pipeline-review-h1-2016/

Furthermore, this report also reviews of key players involved in therapeutic development for Neuropathic Pain and features dormant and discontinued projects. Driven by data built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases...